Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After Bristol-Myers R&D cuts, will AstraZeneca amp up its share of diabetes JV?
Fierce Pharma
Friday, November 8, 2013 - 11:11am
tags:
AstraZeneca, Bristol-Myers Squibb, diabetes
FDA staffers throw cold water on Sanofi's Lemtrada hopes
Fierce Pharma
Friday, November 8, 2013 - 11:10am
tags:
FDA, Sanofi, Lemtrada, MS, multiple sclerosis
Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit
Mass Device
Friday, November 8, 2013 - 11:03am
tags:
JNJ, diagnostics, M&A, Ortho Clinical Diagnostics
Covidien scores Q4, FY2013 earnings beats
Mass Device
Friday, November 8, 2013 - 11:02am
tags:
Covidien, earnings, devices
Janssen Pleads Guilty to Selling Risperdal Off-Label
Bloomberg
Friday, November 8, 2013 - 10:51am
tags:
Janssen, off-label, Risperdal, JNJ
Novo Nordisk And The Danish Delusion
Forbes
Friday, November 8, 2013 - 10:50am
tags:
Novo Nordisk, Denmark, Eli Lilly, diabetes, insulin
Boehringer to bid for poultry vaccine maker Lohmann - sources
Yahoo/Reuters
Friday, November 8, 2013 - 10:48am
tags:
Boehringer, animal health, Lohmann Animal Health, M&A
Dendreon (DNDN) Expected to Report More Narrow Loss
Forbes
Friday, November 8, 2013 - 10:29am
tags:
earnings, Dendreon
Sequenom stock recovers following 3Q report
Yahoo/AP
Friday, November 8, 2013 - 10:06am
tags:
Sequenom, earnings
Peregrine presents data on bavituximab combined with anti-CTLA-4 antibodies
The Fly on the Wall
Friday, November 8, 2013 - 10:05am
tags:
bavituximab, Peregrine Pharmaceuticals, CTLA-4 monoclonal antibody
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup
Xconomy
Friday, November 8, 2013 - 9:42am
tags:
Ariad Pharmaceuticals, layoffs, Iclusig
Sanofi To Manufacture Orexigen’s Contrave
Contract Pharma
Friday, November 8, 2013 - 9:36am
tags:
Sanofi, drug manufacturing, Contrave, Orexigen
Bristol-Myers Ends Some Discovery Work And Cuts R&D Jobs
Pharmalot
Friday, November 8, 2013 - 9:13am
tags:
R&D, Bristol-Myers Squibb, layoffs
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Yahoo/
Friday, November 8, 2013 - 9:13am
tags:
IMMU-132, Immunomedics, solid tumors
Neuroscience? It's Too Risky To Discover Drugs For That
Forbes
Friday, November 8, 2013 - 9:11am
tags:
Bristol-Myers Squibb, R&D, Neuroscience
AbbVie's Not as Vulnerable as the Street Believes
TheStreet.com
Friday, November 8, 2013 - 9:07am
tags:
AbbVie
Amarin's Q3 Call Points To Dark Days Ahead
Seeking Alpha
Friday, November 8, 2013 - 8:39am
tags:
Amarin, earnings
Arena Expands Deal With Eisai on Sales of Obesity Drug
Bloomberg
Friday, November 8, 2013 - 8:36am
tags:
Arena Pharmaceuticals, obesity, Eisai, Belviq
Salix bolsters gastro drug line-up with $2.6 billion Santarus buy
Yahoo/Reuters
Friday, November 8, 2013 - 8:23am
tags:
Salix, Santarus, M&A
EU agency questions AstraZeneca over heart drug trial
Reuters
Thursday, November 7, 2013 - 4:46pm
tags:
Europe, AstraZeneca, Brilinta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.